From the Journals

Polyp detection rates during colonoscopy similar among endoscopists


 

FROM JAMA SURGERY

Adenoma and polyp detection rates during colonoscopy did not vary based on seven different endoscopist characteristics, according to results from a retrospective analysis.

“We sought to assess the association between endoscopist characteristics and adenoma detection rates [ADRs] and proximal sessile serrated polyp detection rates [pSSPDRs],” wrote Shashank Sarvepalli, MD, MS, of the Cleveland Clinic along with his colleagues. The findings were reported in JAMA Surgery.

The researchers conducted a retrospective cohort study of 16,089 patients who underwent screening colonoscopies that were conducted by 56 endoscopists. Data were obtained from the Cleveland Clinic health system during 2015-2017.

Dr. Sarvepalli and his colleagues analyzed seven surgeon characteristics, including time since completion of training, number of colonoscopies performed annually, specialty, and practice setting. Subsequently, they examined the relationships between ADRs and pSSPDRs and these parameters.

“Only patients undergoing normal-risk screening colonoscopies and colonoscopies performed by clinicians who performed more than 100 normal-risk screening colonoscopies during the study period were included,” the researchers wrote.

After analysis, the researchers found that ADR was not significantly associated with any of the characteristics, while pSSPDR was significantly associated with number of years in practice (odds ratio per increment of 10 years, 0.86; 95% confidence interval, 0.83-0.89; P less than .001) and annual colonoscopies completed (OR per 50 colonoscopies annually, 1.05; 95% CI, 1.01-1.09; P = .02).

“After adjusting for additional factors, no difference in detection based on endoscopist characteristics was found,” they added.

The researchers acknowledged that a key limitation of the study was the retrospective design. As a result, the team reported that the findings could be prone to exclusions and misreporting.

No funding sources were reported, and the authors reported no conflicts of interest.

SOURCE: Sarvepalli S et al. JAMA Surg. 2019 Apr 17. doi: 10.1001/jamasurg.2019.0564.

Recommended Reading

Novel microbiome signature may detect NAFLD-cirrhosis
MDedge Internal Medicine
Studies link TMAO to microbiome, reveal new heart disease target
MDedge Internal Medicine
Future of NASH care means multiple targets, multiple providers, expert says
MDedge Internal Medicine
Guidelines demur, but probiotics, curcumin may help in some UC patients
MDedge Internal Medicine
Prevention and Treatment of Traveler’s Diarrhea
MDedge Internal Medicine
DDNA19: The role of the microbiome in liver disease
MDedge Internal Medicine
DDNA19: News and advances in IBD
MDedge Internal Medicine
No biopsy for 21% of adults with celiac disease
MDedge Internal Medicine
Research coalition issues plan for curing hepatitis B virus
MDedge Internal Medicine
Obeticholic acid reversed NASH liver fibrosis in phase 3 trial
MDedge Internal Medicine